ALGS

Aligos Therapeutics, Inc.

$6.50+0.07 (1.09%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Aligos Therapeutics, Inc. (ALGS) is a publicly traded company with 3 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 12 transactions (past 365 days)

ALGS
Principal Accounting…
Award
$66.4K
Aneja Nikhil9,450 shares @ $7.03
Filed 2026-03-11Trade 2026-03-09
ALGS
See Remarks
Award
$263.5K
Calhoun Lesley Ann37,485 shares @ $7.03
Filed 2026-03-11Trade 2026-03-09
ALGS
CEO
Award
$744.1K
Blatt Lawrence105,840 shares @ $7.03
Filed 2026-03-11Trade 2026-03-09
ALGS
See Remarks
Award
$0
Symons Julian A.16,000 shares @ $0.00
Filed 2025-07-18Trade 2025-07-16
ALGS
See Remarks
Award
$0
Calhoun Lesley Ann40,185 shares @ $0.00
Filed 2025-07-18Trade 2025-07-16
ALGS
CEO
Award
$0
Blatt Lawrence179,800 shares @ $0.00
Filed 2025-07-18Trade 2025-07-16
ALGS
Director
Award
$0
Scopa James Paul5,860 shares @ $0.00
Filed 2025-06-26Trade 2025-06-25
ALGS
Director
Award
$0
Martell Bridget A5,860 shares @ $0.00
Filed 2025-06-26Trade 2025-06-25
ALGS
Director
Award
$0
Chavez Margarita5,860 shares @ $0.00
Filed 2025-06-26Trade 2025-06-25
ALGS
Director
Award
$0
Nuechterlein Carole5,860 shares @ $0.00
Filed 2025-06-26Trade 2025-06-25

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →